Chief Operating Officer
CurrentWe are a MedTech company building novel rehabilitation systems based on deep research in neuroplasticity to help Stroke and TBI survivors regain lost hand function.• Led end-to-end product development for the MyHand System, managing a diverse team of engineers, programmers, and clinicians, from concept to commercialization.• Successfully obtained regulatory approvals from FDA, Health Canada, and regulatory bodies of APAC Markets, ensuring compliance and market readiness for the System.• Directed the Healthcare Economics Project, analyzing and justifying the economic value proposition of the IRegained MyHand System which is pivotal to the System adoption.• Led the product requirements planning and ensuring the MyHand System embodying all desired features and benefits for patients and clinicians.• The device has been launched in the market, with early sales, and targeting 40,000 rehab centers across North America and poised to improve the lives of 100 million stroke survivors worldwide.• Achieved preliminary revenues of $30,000 and built a pipeline of over $500,000 in projected revenues for 2024, starting from the pre-revenue stage of the company.• Oversaw a team of 13 staff members, including engineers, programmers, clinicians, an industrial designer, and independent sales representatives.• Find fulfillment in guiding technology from concept to market, managing a high-performing team, and aligning various functions to achieve company goals within resource constraints.• Key experiences to emphasize in professional interviews include navigating challenges during product development, achieving milestones with limited resources, developing comprehensive business plans, and managing internal healthcare economics projects.• Responsibilities include customer development, funding applications, engaging with investors and partners, overseeing manufacturing projects, managing sales pipeline, exploring financing options, and leading marketing efforts.